Send the following on WhatsApp
Continue to Chat預測免疫治療後的存活率! 腫瘤突變負荷量(TMB)可望成為新藥試驗新指標 https://geneonline.news/tmb-predicts-survival-after-immunotherapy-across-multiple-cancer-types/
預測免疫治療後的存活率! 腫瘤突變負荷量(TMB)可望成為新藥試驗新指標 https://geneonline.news/tmb-predicts-survival-after-immunotherapy-across-multiple-cancer-types/